Abstract:Background: According to the US Food and Drug Administration Center for Biologics Evaluation and Research, health care systems have been experiencing blood transfusion overuse. To minimize the overuse of blood product transfusions, a proprietary artificial intelligence (AI)-based blood utilization calculator (BUC) was developed and integrated into a US hospital's electronic health record. Despite the promising performance of the BUC, this technology remains underused in the clinical setting. Objective: This study aims to explore how clinicians perceived this AI-based decision support system and, consequently, understand the factors hindering BUC use. Methods: We interviewed 10 clinicians (BUC users) until the data saturation point was reached. The interviews were conducted over a web-based platform and were recorded. The audiovisual recordings were then anonymously transcribed verbatim. We used an inductive-deductive thematic analysis to analyze the transcripts, which involved applying predetermined themes to the data (deductive) and consecutively identifying new themes as they emerged in the data (inductive). Results: We identified the following two themes: (1) workload and usability and (2) clinical decision-making. Clinicians acknowledged the ease of use and usefulness of the BUC for the general inpatient population. The clinicians also found the BUC to be useful in making decisions related to blood transfusion. However, some clinicians found the technology to be confusing due to inconsistent automation across different blood work processes. Conclusions: This study highlights that analytical efficacy alone does not ensure technology use or acceptance. The overall system's design, user perception, and users' knowledge of the technology are equally important and necessary (limitations, functionality, purpose, and scope). Therefore, the effective integration of AI-based decision support systems, such as the BUC, mandates multidisciplinary engagement, ensuring the adequate initial and recurrent training of AI users while maintaining high analytical efficacy and validity. As a final takeaway, the design of AI systems that are made to perform specific tasks must be self-explanatory, so that the users can easily understand how and when to use the technology. Using any technology on a population for whom it was not initially designed will hinder user perception and the technology's use.

Blood Culture Utilization Optimization: Data-Driven Approaches to Guide Stewardship During Critical Supply Shortages

Every Crisis Is an Opportunity: Advancing Blood Culture Stewardship During a Blood Culture Bottle Shortage

Simulation to optimize the laboratory diagnosis of bacteremia

Clinical and economic evaluation of blood culture whole process optimization in critically ill adult patients with positive blood cultures

Diagnostic Stewardship: A Systematic Review and Meta-Analysis of Blood Collection Diversion Devices Used to Reduce Blood Culture Contamination and Improve the Accuracy of Diagnosis in Clinical Settings

ISO 9001:2015 Internal Audits for Financial and Strategic Decisions in Reducing Blood Culture Contamination

Culture of Cultures: A Small Step Towards Augmenting Diagnostic Stewardship

Work System Assessment to Facilitate the Dissemination of a Quality Improvement Program for Optimizing Blood Culture Use: A Case Study Using a Human Factors Engineering Approach

Effectiveness of multidisciplinary interventions to improve blood culture efficiency and optimize antimicrobial utilization

Dissemination of a Novel Framework to Improve Blood Culture Use in Pediatric Critical Care

Centralized Communication of Blood Culture Results Leveraging Antimicrobial Stewardship and Rapid Diagnostics

An emergency department intervention to improve earlier detection of community-onset bloodstream infection among hospitalized patients

[Reducing Blood Culture Contamination Rates in the Emergency Department]

Using lean management to reduce blood culture contamination

From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization

1541. Impact on Reduction of Blood Culture Incubation Period from Five to Four Days from Large Tertitary Care Center

Clinicians' Perceptions of an Artificial Intelligence-Based Blood Utilization Calculator: Qualitative Exploratory Study

Improving Blood Culture Quality with a Medical Staff Educational Program: A Prospective Cohort Study.

A decision integration strategy for short-term demand forecasting and ordering for red blood cell components

Affordable blood culture systems from China: in vitro evaluation for use in resource-limited settings

Getting rapid diagnostic test data into the appropriate hands by leveraging pharmacy staff and a clinical surveillance platform: a case study from a US community hospital